AEON Biopharma
AEON
AEON Biopharma (AEON) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.60
- EPS estimate
- −$0.35
- EPS surprise
- −71.43%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 12, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 12, 2025 | −$0.35 | −$0.60 | −71.43% | $0.00 | SEC |
| Q1 2025 | May 14, 2025 | −$13.68 | $2.28 | +116.67% | $0.00 | SEC |
| Q4 2024 | Mar 24, 2025 | −$12.96 | $3.75 | +128.94% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$11.52 | −$11.52 | +0.00% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | −$13.68 | $303.84 | +2321.05% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$22.32 | −$228.24 | −922.58% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did AEON Biopharma (AEON) last report earnings?
AEON Biopharma last reported on Aug 12, 2025, covering fiscal Q2 2025.
Did AEON beat earnings estimates?
No. AEON Biopharma reported EPS of −$0.60 for Q2 2025 against a −$0.35 estimate — a 71.43% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.